Pronóstico del mercado europeo de servicios de metabolómica hasta 2028: impacto de COVID-19 y análisis regional por tipo de servicio (servicio de metabolómica dirigido y servicio de metabolómica no dirigido) y aplicación (industria farmacéutica y biotecnológica, tecnología agrícola y medio ambiente)
Introducción al mercado
El mercado europeo de servicios de metabolómica se divide en Alemania, Reino Unido y Francia. , Italia, España y Resto de Europa. La región tiene una cuota de mercado significativa en el mercado de servicios de metabolómica. Europa ocupa una posición significativa en el mercado de servicios de metabolómica y se estima que registrará una sólida tasa de crecimiento durante el período previsto. Se espera que el crecimiento del mercado en la región se deba a la creciente investigación en ciencias biológicas y al aumento de la inversión en investigación y desarrollo. Alemania mantuvo la mayor participación en la región de Europa, ya que tiene la industria de investigación médica más grande de la región europea y es la tercera más grande del mundo. Se espera que el país domine la industria de investigación médica más importante durante el período previsto. Además, Alemania ha sido testigo de un enorme aumento de casos de cáncer en los últimos años; por ejemplo, según el Observatorio Mundial del Cáncer, en 2020 se encontraron un total de 6.28.519 casos nuevos en ambos sexos y todas las edades, 69.697 (11,1%) casos de cáncer de mama, 67.959 (10,8%) Cáncer de próstata, 64.804 (10,3%) Cáncer de pulmón, 57.528 (9,2%) Cáncer colorrectal, 35.147 (5,6%) Cáncer de vejiga y 333.384 (53%) Otros cánceres. Los servicios de metabolómica se utilizan ampliamente en la detección de una amplia gama de metabolitos en tejidos y biofluidos; así, la demanda de servicios de metabolómica está aumentando en el país. El aumento de la adopción de la metabolómica y las inversiones por parte de los actores del mercado es el factor principal que impulsa el crecimiento del mercado europeo de servicios de metabolómica.
El mercado europeo de servicios de metabolómica, según el tipo de servicio, se segmenta en servicio de metabolómica dirigida y servicio de metabolómica no dirigida. El segmento de servicios de metabolómica dirigida lideró el mercado en 2020. La metabolómica dirigida es un método cuantitativo que implica la estimación de un grupo de metabolitos con la ayuda de compuestos de 15N o 13C. Varias empresas ofrecen servicios de metabolómica dirigida. Al cuantificar las moléculas pequeñas y compararlas con los estándares establecidos, pueden dirigirse a los servicios de metabolómica para observar con precisión el proceso metabólico dinámico, revelar los mecanismos metabólicos apropiados y verificar posibles biomarcadores metabólicos. Utilizando sistemas y técnicas LC-MS/MS de última generación, los proveedores de servicios metabólicos ofrecen flujos de trabajo validados de metabolómica específica como vitaminas, aminoácidos, hormonas y muchas moléculas pequeñas.
Visión general y dinámica del mercado
Se espera que el mercado de servicios de metabolómica en Europa crezca desde 128,72 dólares estadounidenses. millones en 2021 a US$ 484,02 millones en 2028; se estima que crecerá a una tasa compuesta anual del 20,8% de 2021 a 2028. Los actores del mercado asociados con la metabolómica están explorando activamente las posibles tecnologías innovadoras para facilitar a los investigadores y la atención médica. Los biomarcadores tienen una amplia aplicación en la terapia personalizada contra el cáncer. Además, los actores del mercado están explorando métodos y tecnologías avanzados para aplicaciones de diagnóstico. Por ejemplo, en abril de 2021, IMAGEENS, una startup de inteligencia artificial (IA) médica con sede en París, aceleró el desarrollo y la comercialización de ArtFun+, un software de inteligencia artificial y sus biomarcadores de pronóstico para imágenes cardiovasculares, y recaudó financiación de € 1,2 millones por lo mismo. Por lo tanto, se espera que estos enfoques innovadores de los actores del mercado abran nuevas posibilidades para el mercado.
Segmentos clave del mercado
El mercado europeo de servicios de metabolómica se ha segmentado según el tipo de servicio, la aplicación y el país. Según el tipo de servicio, el mercado europeo de servicios de metabolómica se segmenta en servicios de metabolómica dirigidos y servicios de metabolómica no dirigidos. El segmento de servicios de metabolómica dirigidos dominó el mercado en 2020 y se espera que sea el de más rápido crecimiento durante el período de pronóstico. Según la aplicación, el mercado se segmenta en industria farmacéutica y biotecnológica, tecnología agrícola y medio ambiente. El segmento de la industria farmacéutica y biotecnológica dominó el mercado en 2020 y se espera que sea el de más rápido crecimiento durante el período previsto. Asimismo, la industria farmacéutica y biotecnológica segmentada se clasifica en descubrimiento de biomarcadores, descubrimiento de fármacos, pruebas toxicológicas y otros.
Principales fuentes y empresas enumeradas
Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el mercado de servicios de metabolómica en Europa son los sitios web de empresas, informes anuales, informes financieros, documentos gubernamentales, y base de datos estadísticos, entre otros. Las principales empresas que figuran en el informe son Afekta Technologies Ltd.; BASF SE; biocrates ciencias de la vida ag; Proteómica Creativa; Centro de Investigación del Cáncer Fred Hutchinson; Metabolon, Inc.; metaSysX; MS-Ómicas; y RTI International son, entre otros.
Informe de razones para comprar
- Comprender el panorama del mercado europeo de servicios de metabolómica e identificar los segmentos de mercado que tienen más probabilidades de garantizar un fuerte retorno
- Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio para el mercado europeo de servicios metabolómicos
- Planifique eficientemente fusiones y adquisiciones y acuerdos de asociación en el mercado de servicios de metabolómica de Europa mediante la identificación de segmentos de mercado con las ventas probables más prometedoras
- Ayuda a tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo del desempeño del mercado de varios segmentos de Europa Mercado de servicios de metabolómica
- Obtener pronóstico de ingresos de mercado para varios segmentos desde 2021-2028 en la región de Europa.
Segmentación del mercado de servicios de metabolómica en Europa
Metabolómica en Europa Mercado de servicios: por tipo de servicio
- servicio de metabolómica dirigido
- Servicio de metabolómica no dirigido
Mercado de servicios de metabolómica en Europa, por aplicación
- Industria farmacéutica y biotecnológica
- Descubrimiento de biomarcadores
- Descubrimiento de fármacos
- Pruebas toxicológicas
- Otros
- Agritech
- Medio ambiente
Mercado europeo de servicios de metabolómica: por país
- EE.UU.
- Canadá
- México
Mercado de servicios de metabolómica en Europa -Perfiles de empresas
- Alemania
- Francia
- Reino Unido
- Italia
- España
- Resto de Europa
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Metabolomics Services Market – By Service Type
1.3.2 Europe Metabolomics Services Market – By Application
1.3.3 Europe Metabolomics Services Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Metabolomics Services Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Metabolomics Services Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Uprising Incidences of Cancer
5.1.2 Rise in Adoption of Metabolomics and Investments by Market Players
5.2 Market Restraints
5.2.1 High Cost of Tools, Instruments, and Usage
5.3 Market Opportunities
5.3.1 Growth Opportunities in Several Countries
5.4 Future Trends
5.4.1 Use of Artificial Intelligence (AI) and Biomarkers in Biomarker-Related Analysis and Personalized Therapy
5.5 Impact Analysis
6. Metabolomics Services Market– Europe Analysis
6.1 Europe Metabolomics Services Market Revenue Forecast and Analysis
7. Europe Metabolomics Services Market Revenue and Forecasts to 2028– by Service Type
7.1 Overview
7.2 Europe Metabolomics Services Market, By Service Type 2021 & 2028 (%)
7.3 Targeted Metabolomics Service
7.3.1 Overview
7.3.2 Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Untargeted Metabolomics Service
7.4.1 Overview
7.4.2 Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
8. Europe Metabolomics Services Market Revenue and Forecasts to 2028 – by Application
8.1 Overview
8.2 Europe Metabolomics Services Market Share by Application 2021 & 2028 (%)
8.3 Pharmaceutical and Biotechnology Industry
8.3.1 Overview
8.3.2 Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.1 Biomarker Discovery
8.3.2.1.1 Overview
8.3.2.1.2 Biomarker Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.2 Toxicological Testing
8.3.2.2.1 Overview
8.3.2.2.2 Toxicological Testing: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.3 Drug Discovery
8.3.2.3.1 Overview
8.3.2.3.2 Drug Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.4 Others
8.3.2.4.1 Overview
8.3.2.4.2 Others: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Agritech
8.4.1 Overview
8.4.2 Agritech: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Environment
8.5.1 Overview
8.5.2 Environment: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
9. Europe Metabolomics Services Market Revenue and Forecasts to 2028 – Country Analysis
9.1.1 Europe: Metabolomics Services Market, by Country, 2021 & 2028(%)
9.1.1.1 Germany: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 Germany: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 Germany: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.3 Germany: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.3.1 Germany: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.2 France: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 France: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.3 France: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.3.1 France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.3 UK: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 UK: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 UK: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.3 UK: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.3.1 UK: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.4 Italy: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 Italy: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 Italy: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.3 Italy: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.3.1 Italy: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.5 Spain: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.1 Spain: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2 Spain: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.3 Spain: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.3.1 Spain: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
9.1.1.6 Rest of Europe: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.1 Rest of Europe: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2 Rest of Europe: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.3 Rest of Europe: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.3.1 Rest of Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Europe Metabolomics Services Market
10.1 Overview
11. Europe Metabolomics Services Market–Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 BASF SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Creative Proteomics
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 RTI International
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Afekta Technologies Ltd.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fred Hutchinson Cancer Research Center
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Metabolon, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 biocrates life sciences ag
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 metaSysX
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MS-Omics
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Metabolomics Services Market Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Germany: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 5. France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 6. France: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. France: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UK: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 9. UK: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. UK: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 11. Italy: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Italy: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Italy: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 14. Spain: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Spain: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Spain: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Europe: Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Europe: Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Europe: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 20. organic Developments Done By Companies
Table 21. Inorganic Developments Done By Companies
Table 22. Glossary of Terms, Metabolomics Services Market
LIST OF FIGURES
Figure 1. Europe Metabolomics Services Market Segmentation
Figure 2. Europe Metabolomics Services Market, By Country
Figure 3. Europe Metabolomics Services Market Overview
Figure 4. Targeted Metabolomics Service Segment Held Largest Share of Type Segment in Europe Metabolomics Services Market
Figure 5. Germany is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Europe Impact Analysis of Drivers and Restraints Pertaining to Metabolomics Services Market
Figure 9. Europe Metabolomics Services Market– By Revenue Forecast and Analysis – 2019- 2028
Figure 10. Europe Metabolomics Services Market, by Service Type 2021 & 2028 (%)
Figure 11. Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Europe Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Europe Metabolomics Services Market Share by Application 2021 & 2028 (%)
Figure 14. Europe Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 15. Europe Biomarker Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 16. Europe Toxicological Testing: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 17. Europe Drug Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 18. Europe Others : Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19. Europe Agritech: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. Europe Environment: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. Europe: Metabolomics Services Market, by Key Country – Revenue (2021) (USD Million)
Figure 22. Europe: Metabolomics Services Market, by Country, 2021 & 2028 (%)
Figure 23. Germany: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. France: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. UK: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Italy: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Spain: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of Europe: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in European Country Markets
- Afekta Technologies Ltd.
- BASF SE
- biocrates life sciences ag
- Creative Proteomics
- Fred Hutchinson Cancer Research Center
- Metabolon, Inc.
- metaSysX
- MS-Omics
- RTI International
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Metabolomics Services market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe Metabolomics Services market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Metabolomics Services market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution